Get your patient on Sodium Acetate - Sodium Acetate injection, Solution, Concentrate (Sodium Acetate)
Sodium Acetate - Sodium Acetate injection, Solution, Concentrate prescribing information
INDICATIONS AND USAGE
Sodium Acetate Injection, USP is indicated as a source of sodium for addition to large volume intravenous fluids to prevent or correct hyponatremia in patients with restricted or no oral intake. It is also useful as an additive for preparing specific intravenous fluid formulas when the needs of the patient cannot be met by standard electrolyte or nutrient solutions.
DOSAGE AND ADMINISTRATION
Sodium Acetate Injection, USP is administered intravenously only after dilution in a larger volume of fluid . The dose and rate of administration are dependent upon the individual needs of the patient. Serum sodium should be monitored as a guide to dosage. Using aseptic technique, transfer the desired amount to other intravenous fluids to provide the appropriate number of milliequivalents (mEq) of sodium acetate.
Sodium Acetate Injection, USP in the Pharmacy Bulk Package is designed for use with manual, gravity flow operations and automated compounding devices for preparing intravenous nutritional admixtures. Admixtures must be stored under refrigeration and used within 24 hours after compounding.
Parenteral drug products should be inspected visually for particulate matter and discoloration prior to administration. (See PRECAUTIONS .)
Directions for Dispensing From Pharmacy Bulk Package
The Pharmacy Bulk Package is for use in the Pharmacy Admixtures Service only. For hanger application, peel off the paper liner from both ends of the tape hanger to expose ¾ inch long adhesive portions. Adhere each end to the label on the bottle. The vials should be suspended as a unit in the laminar flow hood.
A single entry through the vial closure should be made with a sterile dispensing set or transfer device. Transfer individual doses to appropriate intravenous infusion solutions. Use of a syringe with needle is not recommended as it may cause leakage and multiple entries will increase the potential of microbial and particulate contamination.
The above process should be carried out under a laminar flow hood using aseptic technique.
Discard any unused portion within 4 hours after initial closure entry.
CONTRAINDICATIONS
Sodium Acetate Injection, USP is contraindicated in patients with hypernatremia or fluid retention.
ADVERSE REACTIONS
Sodium overload can occur with intravenous infusion of excessive amounts of sodium-containing solutions. (See WARNINGS and PRECAUTIONS .)
DESCRIPTION
Sodium Acetate Injection, USP is a sterile, nonpyrogenic, concentrated solution of sodium acetate in water for injection. The solution is administered after dilution by the intravenous route as an electrolyte replenisher. It must not be administered undiluted. Each mL of 2 mEq/mL product contains 164 mg of sodium acetate (anhydrous) which provides 2 mEq each of sodium (Na + ) and acetate (CH 3 COO - ). Each mL of 4 mEq/mL product contains 328 mg of sodium acetate (anhydrous) which provides 4 mEq each of sodium (Na + ) and acetate (CH 3 COO - ). The solution contains no bacteriostat, antimicrobial agent or added buffer. May contain acetic acid for pH adjustment; the pH is 6.5 (6.0 to 7.0). The osmolar concentration is 4 mOsmol/mL (calc.) in 2 mEq/mL product and 8 mOsmol/mL (calc.) in 4 mEq/mL product; specific gravity 1.081(2 mEq/mL) and 1.1511 (4 mEq/mL).
The solution is intended as an alternative to sodium chloride to provide sodium ion (Na + ) for addition to large volume infusion fluids for intravenous use.
Sodium Acetate, USP anhydrous is chemically designated CH 3 COONa, a hygroscopic powder very soluble in water.
A Pharmacy Bulk Package is a container of a sterile preparation for parenteral use that contains many single doses. The contents are intended for use in a pharmacy admixture program and are restricted to the preparation of admixtures for intravenous infusion.
CLINICAL PHARMACOLOGY
Sodium is the principal cation of extracellular fluid. It comprises more than 90% of total cations at its normal plasma concentration of approximately 140 mEq/liter. The sodium ion exerts a primary role in controlling total body water and its distribution.
Acetate (CH 3 COO - ) is a hydrogen ion acceptor. It also serves as an alternate source of bicarbonate (HCO 3 - ) by metabolic conversion in the liver. This conversion has been shown to proceed readily, even in the presence of severe liver disease.
HOW SUPPLIED
Sodium Acetate Injection, USP is supplied in Pharmacy Bulk Packages as follows:
NDC No. | Fill Volume | Na + | Acetate | Concentration |
71357-007-01 – Glass Fliptop Vial 71357-007-10 – Case Containing 10 Units | 50 mL | 100 mEq | 100 mEq | 16.4% |
71357-008-01 – Glass Fliptop Vial 71357-008-10 – Case Containing 10 Units | 100 mL | 200 mEq | 200 mEq | 16.4% |
71357-009-01 – Glass Fliptop Vial 71357-009-10 – Case Containing 10 Units | 100 mL | 400 mEq | 400 mEq | 32.8% |
Store at 20 to 25ºC (68 to 77ºF). [See USP Controlled Room Temperature.]
